ストックスクリーナーアプリを入手
16.07
4.08%
0.63
アフターアワーズ：
15.75
-0.32
-1.99%
Lb Pharmaceuticals Inc (LBRX) 最新ニュース
Analysts Set LB Pharmaceuticals Inc (NASDAQ:LBRX) PT at $30.50 - Defense World
LB Pharmaceuticals (NASDAQ:LBRX) Raised to Hold at Zacks Research - MarketBeat
LB Pharmaceuticals Inc (NASDAQ:LBRX) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Biopharma financings climb to $18.7B in the third quarter - BioWorld MedTech
Q3 Earnings Forecast for LBRX Issued By Leerink Partnrs - MarketBeat
LB Pharmaceuticals (NASDAQ:LBRX) Stock Rating Upgraded by Leerink Partnrs - Defense World
September biopharma financings jump 54% to $7.12B - BioWorld MedTech
LB Pharmaceuticals (NASDAQ:LBRX) Upgraded at Leerink Partnrs - MarketBeat
LB Pharmaceuticals (NASDAQ:LBRX) Coverage Initiated by Analysts at Leerink Partners - Defense World
LB Pharmaceuticals to Present Three Posters at 38th ECNP Congress Highlighting Clinical Activity and Safety Profile of LB-102 in Schizophrenia, Including Positive Effects on Cognition and Negative Symptoms - Sahm
Drug developer MapLight eyes $704.3 million valuation in US IPO - Reuters
LB Pharmaceuticals to Present Three Posters at 38th ECNP - GlobeNewswire
Leerink Partners Initiates LB Pharmaceuticals(LBRX.US) With Buy Rating, Announces Target Price $34 - 富途牛牛
Buy Rating for LB Pharmaceuticals Driven by Promising LB-102 and Market Potential - TipRanks
Leerink Partners Initiates LB Pharmaceuticals at Outperform With $34 Price Target - MarketScreener
0.66 effect size in cognition: LB Pharma's LB‑102 shows dose‑dependent gains; 3 ECNP posters Oct 11-14 - Stock Titan
LB Pharmaceuticals (NASDAQ:LBRX) Now Covered by Analysts at Leerink Partners - MarketBeat
LB Pharmaceuticals stock initiated at Outperform by Leerink Partners - Investing.com
Promising Prospects for LB Pharmaceuticals: Buy Rating Affirmed on LB-102’s Market Potential - TipRanks
Piper Sandler initiates coverage on LB Pharmaceuticals stock with Overweight rating - Investing.com
Stifel initiates coverage on LB Pharmaceuticals stock with Buy rating - Investing.com
LB Pharmaceuticals IncCommon Stock (Nasdaq:LBRX) Stock Quote - FinancialContent
LB Pharmaceuticals Appoints William Kane and Rekha Hemrajani To Board - citybiz
LB Pharmaceuticals adds two directors following Nasdaq debut By Investing.com - Investing.com Nigeria
LB Pharmaceuticals adds two directors following Nasdaq debut - Investing.com India
LB Pharmaceuticals Strengthens Board of Directors with Appointments of William Kane and Rekha Hemrajani - The Manila Times
Strategic Board Expansion: LB Pharmaceuticals Strengthens Leadership for Phase 3 Schizophrenia Drug Trial - Stock Titan
Scoop: Voltron Therapeutics plans IPO next year - Axios
Deep Track Capital, LP Acquires Significant Stake in LB Pharmaceuticals Inc - GuruFocus
RA CAPITAL MANAGEMENT, L.P. Acquires Significant Stake in LB Pha - GuruFocus
COMMODORE CAPITAL LP Acquires 1,225,000 Shares in LB Pharmaceuti - GuruFocus
Deep Track Capital, LP Acquires Significant Stake in LB Pharmace - GuruFocus
LB Pharmaceuticals (NASDAQ:LBRX) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
Big Pharma-backed MapLight plots IPO to advance neuro pipeline - fiercebiotech.com
Novo-Backed Drug Developer MapLight Therapeutics Files for IPO - Bloomberg.com
Neuro drug developer LB Pharma seeks $300M+ valuation in U.S. IPO - MSN
Layoff Tracker: Arsenal, X4 Lay Off Half of Staff to Cut Costs - BioSpace
Hedge Fund and Insider Trading News: Ray Dalio, Bill Ackman, Warren Buffett, Steve Cohen, Mario Gabelli, Balyasny Asset Management, LB Pharmaceuticals Inc (LBRX), Avista Corp (AVA), and More - Insider Monkey
Schizophrenia drug developer LB Pharma jumps in trading debut - MSN
Wednesday 9/17 Insider Buying Report: LBRX, RAPP - Nasdaq
Major Investors Make Bold Moves in LB Pharmaceuticals Stock! - TipRanks
Vida Ventures raises $5.0m in LB Pharmaceuticals (LBRX) By Investing.com - Investing.com Nigeria
LB Pharmaceuticals Launches $285 Million Initial Public Offering - Global Legal Chronicle
Vida Ventures raises $5.0m in LB Pharmaceuticals (LBRX) - Investing.com
Finance Watch: LB Pharmaceuticals Launches Second-Largest Biopharma IPO Of 2025 In The US - insights.citeline.com
1.11%
大文字化:
|
ボリューム (24 時間):